Stay updated with breaking news from Resented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research, presented by AstraZeneca, provides information on the biological validation of Serum Response Factor as a potential target for idiopathic pulmonary fibrosis The target was discovered
GENEVA, May 31, 2023 /PRNewswire/ -- 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study
This Study and Others Presented at the EULAR European Congress of Rheumatology 2023 CreakyJoints®, the digital, international patient community for people with all forms of arthritis and part of
-- New data illustrate impact of KRYSTEXXA (pegloticase) injection with methotrexate to improve patient outcomes and clinical measures for uncontrolled gout -- Horizon Therapeutics plc (Nasdaq: HZNP)
BOHEMIA, NY / ACCESSWIRE / May 31, 2023 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today that the